CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
REVENUES:
Product revenue, net	$ 7,768
COSTS AND EXPENSES:
Cost of sales	4,741
Research and development	86,655	81,876
General and administrative	34,752	30,215
Total Operating Expenses	126,148	112,091
Operating loss	(118,380)	(112,091)
Other income, net	1,722	1,873
Net loss	(116,658)	(110,218)
Preferred stock deemed dividend		6,659
Net loss available to common stockholders	$ (116,658)	$ (116,877)
Net loss per common share, basic	$ (6.85)	$ (20.01)
Net loss per common share, diluted	$ (6.85)	$ (20.01)
Weighted average common shares outstanding, basic	17,039,309	5,841,447
Weighted average common shares outstanding, diluted	17,039,309	5,841,447